NCT00114569View on ClinicalTrials.gov

Lorazepam for the Treatment of Status Epilepticus in Children

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

February 28, 2009

Conditions
Status Epilepticus
Interventions
DRUG

lorazepam

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

All Listed Sponsors
collaborator

The Emmes Company, LLC

INDUSTRY

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00114569 - Lorazepam for the Treatment of Status Epilepticus in Children | Biotech Hunter | Biotech Hunter